https://www.aigom.it/wp-content/uploads/2026/02/ART3.2.png1172700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-03 08:31:362026-02-03 08:31:36ADJUVANT EPIRUBICIN PLUS CYCLOPHOSPHAMIDE FOLLOWED BY TAXANES WITH OR WITHOUT CARBOPLATIN IN EARLY-STAGE TRIPLE-NEGATIVE BREAST CANCER (RJBC 1501): A RANDOMIZED PHASE III TRIAL.
https://www.aigom.it/wp-content/uploads/2026/01/ART27.1.png1120700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-27 09:05:342026-01-27 09:05:34MANAGEMENT OF CANCER DURING PREGNANCY: ASCO GUIDELINE-2026
https://www.aigom.it/wp-content/uploads/2026/01/ART20.1.png973700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-20 08:30:502026-01-20 08:30:50STRUCTURED EXERCISE AFTER ADJUVANT CHEMOTHERAPY FOR COLON CANCER.
https://www.aigom.it/wp-content/uploads/2026/01/Screenshot-2026-01-27-105547.png1041747Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-14 15:57:552026-01-27 09:57:39AIGOM-20/21 MARZO 2026, VERONA-PROGETTO CANOA 16° EDIZIONE-CARCINOMA MAMMARIO: QUALI NOVITA’ PER IL 2026?
https://www.aigom.it/wp-content/uploads/2026/01/ART13.1.png1073760Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-13 09:28:182026-01-13 09:28:18PREVALENCE AND ASSOCIATED FACTORS OF CHRONIC PAIN AMONG NURSES: A NATIONAL CROSS-SECTIONAL STUDY.
https://www.aigom.it/wp-content/uploads/2025/12/Screenshot-2025-12-22-183958.png7851129Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-12-22 17:48:512025-12-22 17:48:51AIGOM-2026: GIST AVANZATI E IL VALORE DELLA GESTIONE MULTIDISCIPLINARE DEL PAZIENTE-VERONA 25 FEBBRAIO 2026
https://www.aigom.it/wp-content/uploads/2025/12/ART2.12.png1133700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-12-02 08:20:352025-12-01 14:39:05POSTMASTECTOMY RADIATION THERAPY: AN ASTRO/ASCO/SSO CLINICAL PRACTICE GUIDELINE.
https://www.aigom.it/wp-content/uploads/2025/11/ART25.11.png1193743Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-25 11:13:322025-11-25 11:13:32CLINICAL CHARACTERIZATION OF FGFR2b EXPRESSION IN PATIENTS WITH ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
https://www.aigom.it/wp-content/uploads/2025/11/ART18.11-1.png738588Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-18 12:11:462025-11-25 13:01:27ESGO-ESTRO-ESP GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ENDOMETRIAL CARCINOMA: UPDATE 2025.
